COVID-19 Impact on Costs for Breast Surgery Patients

Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery

Recruiting Observational Study
Breast Ductal Carcinoma In Situ COVID-19 Infection Hereditary Breast Carcinoma Invasive Breast Carcinoma
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Study type
Observational
Participants needed
600 (estimated)
Sponsor
M.D. Anderson Cancer Center · Other
Who this trial is looking for

This trial is looking for breast cancer patients who are planning to undergo surgery. Participants will provide information about their costs and experiences related to surgery during the COVID-19 pandemic.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have a diagnosis of invasive breast cancer or ductal carcinoma in situ.
  • I speak English.
  • I can complete consent forms.
  • I can fill out computer surveys.

You may not be able to join if

  • I do not speak English.
  • I have recurrent or metastatic breast cancer.
  • I have more than one type of cancer at the same time.
  • I am having breast conservation therapy.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
This study investigates the impact of COVID-19 pandemic on out-of-pocket costs, lost wages, and unemployment in patients with breast cancer undergoing breast surgery. Post-mastectomy reconstructive patients are at high risk for financial toxicity (adverse effects of escalating health care cost on well-being). The goal of this study is to collect information about financial costs patients may have …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Have an indication for surgical treatment of invasive breast cancer or ductal breast carcinoma in situ (DCIS) or prophylaxis in the setting of genetic mutations or strong family history * English-speaking * Able to complete consent * Able to fill out computer survey material …
Contacts

Carrie Chu, MD

713-794-1247

ckchu@mdanderson.org

CONTACT